Merck's Blockbuster Cancer Antibody Racks Up Another Approval
BioSpace
MAY 5, 2021
FDA approved Keytruda combined with Genentech’s Herceptin (trastuzumab), fluoropyrimidine- and platinum-containing chemotherapy, for first-line treatment of locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma.
Let's personalize your content